Date: 06/12/2024

The researchers found that revertant somatic recombination could be used for a pioneering therapy. By making grafts called cultured epidermal autografts (CEAs), which contain genetic mutation corrections that give healthy skin, and grafting these naturally corrected skin cells to affected areas, outbreaks of the disease could be controlled.

https://www.sciencedaily.com/releases/2024/06/240610202934.htm